Efficacy of Platelet-rich-Fibrin Gel in Patients With Chronic Leg Ulcers
Pak Emirates Military Hospital
40 participants
Dec 16, 2025
INTERVENTIONAL
Conditions
Summary
Platelet rich Fibrin (PRF) gel is an emerging as a novel treatment option for chronic leg ulcers and has the potential to become the 1st line option in these conditions. The objective of our study will be to assess the efficacy of PRF gel dressing in patients with non-infective chronic leg ulcers.
Eligibility
Inclusion Criteria1
- All male and female patients more than 35 years old with Chronic Leg Ulcers, presenting to the OPD will be included.
Exclusion Criteria1
- Patients with clinical signs of infected ulcers, patients in sepsis and immunosuppressed individuals will be excluded.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
PRF is derived solely from the patient's own blood and does not contain any non-autologous additives, such as anticoagulants or bovine thrombin, as first-generation platelet concentrates (like some forms of PRP)
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07294521